TY - JOUR
AU - S. Aloe
AU - C. Filliter
AU - S. Salmasi
AU - S. Igweokpala
AU - O. H. Y. Yu
AU - V. Tagalakis
AU - K. Filion
AD - Department of Endocrinology & Metabolism, McGill University, Montreal, Quebec, Canada.
Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
Division of Endocrinology and Metabolism, Jewish General Hospital/McGill University, Montreal, Quebec, Canada.
Division of General Internal Medicine, Jewish General Hospital/McGill University, Montreal, Quebec, Canada.
Department of Medicine, McGill University, Montreal, Quebec, Canada.
AN - 37183930
BT - Br J Clin Pharmacol
DO - 10.1111/bcp.15787
DP - NLM
ET - 2023/05/15
LA - eng
N1 - 1365-2125
Aloe, Stephanie
Filliter, Christopher
Salmasi, Shahrzad
Igweokpala, Samuel
Yu, Oriana H Y
Tagalakis, Vicky
Filion, Kristian B
Orcid: 0000-0001-6055-0088
Journal Article
England
Br J Clin Pharmacol. 2023 May 15. doi: 10.1111/bcp.15787.
PY - 2023
SN - 0306-5251
T2 - Br J Clin Pharmacol
TI - SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study
ER -